×
For best experience we recommend to activate Javascript in your browser.
Neuregulin 4 antibody (AA 1-62)
The Rabbit Polyclonal anti-Neuregulin 4 antibody has been validated for IHC, WB, IP and ICC. It is suitable to detect Neuregulin 4 in samples from Mouse.
Quick Overview for Neuregulin 4 antibody (AA 1-62) (ABIN7623371)
Target
See all Neuregulin 4 (NRG4) Antibodies
Neuregulin 4 (NRG4)
Reactivity
All reactivities for Neuregulin 4 antibodies
Mouse
Host
All hosts for Neuregulin 4 antibodies
Rabbit
Clonality
All clonalities for Neuregulin 4 antibodies
Polyclonal
Conjugate
All conjugates for Neuregulin 4 antibodies
This Neuregulin 4 antibody is un-conjugated
Application
All applications for Neuregulin 4 antibodies
Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-Neuregulin 4 Antibody
(hide)
Binding Specificity
All epitopes for Neuregulin 4 antibodies
AA 1-62
Purpose
Neuregulin 4 (NRG4) Polyclonal Antibody
Sequence
Met1~Ser62
Characteristics
The Neuregulin 4 (NRG4) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Protein A + Protein G affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.78 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for Neuregulin 4
(hide)
Target
Neuregulin 4 (NRG4)
Alternative Name
NRG4
Gene ID
83961
UniProt
Q9WTX4
Pathways
RTK Signaling , Fc-epsilon Receptor Signaling Pathway , EGFR Signaling Pathway , Neurotrophin Signaling Pathway
Recently viewed
(hide)
Chat with us , powered by LiveChat